STTCOMP PAA FA Long
Soi 387 mil
Mkt cap $147 mil
Last traded 38 cents
PAA ia biotech company conducting trials for treatment of MND Motor Nueron Disease
Released results of phase 2 trials after market today.
I sold out of PAA Friday but todays results are great. No safety issues and the bottom line is
Using the prognostic predictor model described in Elamin et al., 2015, 1 depending on the current severity of the disease, a 0.48 slope change as calculated for all 12 patients could provide patients with an additional 13.5- 56.5 months in median survival. Currently approved treatments for ALS/MND provide approximately 2 – 9 months in
additional life expectancy.
So PAA kick life expectancy 5 times longer than the current $1 b companies treatment.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 26 Feb
STTCOMP PAA FA LongSoi 387 milMkt cap $147 milLast traded 38...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)